---
annotations:
- type: Pathway Ontology
  value: G protein mediated signaling pathway
authors:
- ReactomeTeam
- DeSl
- Eweitz
description: Rhodopsin-like receptors (class A/1) are the largest group of GPCRs and
  are the best studied group from a functional and structural point of view. They
  show great diversity at the sequence level and thus, can be subdivided into 19 subfamilies
  (Subfamily A1-19) based on a phylogenetic analysis (Joost P and  Methner A, 2002).
  They represent members which include hormone, light and neurotransmitter receptors
  and encompass a wide range of functions including many autocrine, paracrine and
  endocrine processes.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=373076
  Reactome].
last-edited: 2021-05-07
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4419
- /instance/WP4419
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4419.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Rhodopsin-like receptors (class A/1) are the largest group of GPCRs
    and are the best studied group from a functional and structural point of view.
    They show great diversity at the sequence level and thus, can be subdivided into
    19 subfamilies (Subfamily A1-19) based on a phylogenetic analysis (Joost P and  Methner
    A, 2002). They represent members which include hormone, light and neurotransmitter
    receptors and encompass a wide range of functions including many autocrine, paracrine
    and endocrine processes.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=373076
    Reactome].
  keywords:
  - 'DTTA '
  - PTGFR
  - TXA2
  - 'P2RY4 '
  - 'TAAR9 '
  - AGTR2:AGT(34-41)
  - PTGDR
  - 'AVPR1B '
  - 'CNR2 '
  - 'TSHB '
  - 'PEA '
  - 'ANXA1 '
  - 'CX3CR1 '
  - 'HTR1F '
  - 'S1PR1 '
  - activated thrombin
  - PGF2a
  - 'prazosin '
  - 'XK '
  - C3AR1:C3a
  - UDP
  - PGD2
  - 'PGI2 '
  - NMU
  - P2RY1:ADP
  - '18(R)-RvE1 '
  - 'FPR2 '
  - EDNRA,EDNRB:Endothelin
  - 'TAAR6 '
  - NPFFR1,NPFFR2:NPFF(69-76)
  - 'TBXA2R '
  - Opsins:photon
  - 'UTP '
  - amine-associated
  - Neuropeptides
  - DRD1,5:DA
  - RXFP3
  - 'RGR '
  - Thyrostimulin
  - G alpha (s)
  - HRH3
  - 'CHRM1 '
  - QRFPR
  - RXFP4 ligands
  - 'CXCR6 '
  - CCL13:CCL2,CCR3
  - cortistatin
  - 'GNRH1(24-33) '
  - 'RRH '
  - FPR2:FPR2 ligands
  - 'GLA '
  - CYSLTR1 antagonists
  - CCR9:CCL25
  - QRFPR:QRFP
  - MLN(26-47)
  - FFAR3:FFAR3 ligands
  - 'F2RL2(22-374) '
  - ATP
  - 'NMBR '
  - 'CHRM2 '
  - 'CXCL3(35-107) '
  - 'S1PR4 '
  - GALR1-3
  - 'arformoterol '
  - S1PR1 agonists
  - 'LPAR2 '
  - 'Pmoa '
  - CXCR3 ligands
  - 'GPR4 '
  - FFAR4:FFAR4 ligands
  - TBXA2R:TXA2
  - 'CCL5(24-91) '
  - ADRB1,2,3:Î²-blockers
  - 'P2RY10 '
  - KISS1(68-121)
  - 'PTGER1 '
  - 'HCAR2 '
  - ADORA2A,B
  - 'ADR '
  - P2RY9:LPA
  - 'CXCL13 '
  - HCRTR1:HCRT(34-66)
  - 'FSHR '
  - 'NPSR1 '
  - 'OPRL1 '
  - HTR1B,D,E,F,HTR5A
  - PAF receptor:PAF
  - Proteinase-activated
  - 'INSL5(23-48) '
  - 'DRD3 '
  - NMS
  - 'CCL23-2 '
  - FFAR2:FFAR2 ligands
  - 'NPW(33-55) '
  - 'PRLH(34-53) '
  - C5AR2
  - ADORA1,3
  - HRH1:Hist
  - 'HXA '
  - CHRM1,3,5:AcCho
  - P2RY12:ADP
  - FMLP
  - 'OPN1MW '
  - TRHR
  - RXFP4:RXFP4 ligands
  - TAC1(58-68)
  - 'OXER1 '
  - NTS(151-160)
  - 'siponimod '
  - 'GPBAR1 '
  - 'KISS1(68-121) '
  - 'GPR132 '
  - 'CYSLTR2 '
  - 'LPAR6 '
  - CXCR3
  - 'CCRL2 '
  - 'CCL27 '
  - RXFP2:RXFP2 ligands
  - ADR, NAd
  - 'TRH(227-229) '
  - LTC4,LTD4,LTE4
  - HCAR3:HCAR3 ligands
  - 'MC2R '
  - 'LPPR2 '
  - 'NPFFR2 '
  - TACR2:TAC1(98-107)
  - 'DecS-GHRL-1(24-50) '
  - 'TAAR3 '
  - ADRB3:ADR,NAd
  - 'NMS '
  - POMC(138-176):MC2R
  - 'ADRA2B '
  - 'PPY(30-65) '
  - ADP
  - HCRTR2
  - 'RXFP3 '
  - 'UTS2B '
  - 'ADRB3 '
  - CCL25
  - receptor:neuropeptides B/W
  - 'CXCR5 '
  - GPR37:PSAP fragments
  - 'DRD4 '
  - 'ADRA1B '
  - 'OPRD1 '
  - HCAR2
  - 'APLN(65-77) '
  - Melanospin:photon
  - 'NTS(151-163) '
  - 'UDP-Glc '
  - 'AVPR2 '
  - MCHR1,MCHR2:PMCH(147-165)
  - 'LPAR1 '
  - RXFP4
  - LTB4R,LTB4R2
  - 'GPR65 '
  - ARBs:AGTR1
  - CCL1
  - metabolism
  - 'LTB4R '
  - CCR6
  - 'AEA '
  - 'RLN2(25-53) '
  - 'PPBP(35-128) '
  - Î²3-agonists:ADBR3
  - receptor:somatostatin
  - 'NPY1R '
  - C5AR1:C5a
  - 'CCRL1 '
  - CXCR2
  - NPS
  - GPBAR1
  - P2RY13
  - 'Pentadecanoic acid '
  - 'Ca2+ '
  - OXGR1:2OG
  - Acyl ghrelin:GHSR
  - HCRT(34-66)
  - CXCR1
  - 'NCA '
  - 'HCRT(70-97) '
  - C5AR1
  - 'MLN(26-47) '
  - 'LPAR4 '
  - receptor
  - 5HT
  - 'CORT(89-105) '
  - 'RHO '
  - 'CCR10 '
  - P2RY11 :ATP
  - 'PTGDR2 '
  - 'OPN1LW '
  - 'PTGER2 '
  - 'thrombin heavy chain '
  - P2RY12
  - NTSR1,NTSR2:NTS(151-163)
  - DRD2:DA
  - RXFP3:Relaxin-3
  - HCAR1
  - HCRTR2:HCRT(70-97)
  - TACR3:TAC3
  - 'carvedilol '
  - 'PNOC(130-146) '
  - CCRL2:CCL19
  - S1PR2-5
  - 'SSTR1 '
  - 'CCK '
  - MSH
  - 'NPFFR1 '
  - CXCL13
  - 'CCL4(24-92) '
  - GPR37L1:Prosaposin
  - C3AR1
  - 'TAC1(98-107) '
  - 'CCL21 '
  - Bradykinin receptor
  - B/W
  - HRH1
  - 7alpha,25-dihydroxycholesterol
  - ADRB2:ADR,NAd
  - 'RLN3(119-142) '
  - 'XCL2 '
  - 'OLEA '
  - 'CCR7 '
  - 'DHA '
  - 'PPYR1 '
  - CXCL12(22-93)
  - 'TRH(186-188) '
  - AGTR1:AGT(34-41)
  - 'SAA1(19-122) '
  - EDN3(97-117)
  - GPR143:L-Dopa
  - 'CX3CL1 '
  - CCBP2 ligands
  - '12(S)-HETE '
  - EDN3(97-238)
  - 'PROKR2 '
  - PTGER3
  - Somatostatin,
  - 'AGT(34-41) '
  - 'SSTR5 '
  - POMC(138-176)
  - '3-hydroxyoctanoic acid '
  - 'Hist '
  - SUCCA
  - 'CXCL12(22-93) '
  - Î²1,2-agonists:ADBR1,2
  - 'GPR55 '
  - 'MC1R '
  - AGTR2
  - 'C5a '
  - AGTR1
  - 'PENK(210-214) '
  - C5AR2:C5AR2 ligands
  - CCR11:CCL19,21,25
  - 'LPPR5 '
  - P2RY5:LPA
  - 'XCL1 '
  - HTR1A
  - 'TACR3 '
  - 'HTR2C '
  - 'HTR1A '
  - 'EPA '
  - CCL5(24-91)
  - Nociceptin
  - LPAR1,2,3,5
  - S1PR1
  - 'NPW(33-62) '
  - HCAR2 ligands
  - FPR3
  - Melatonin receptors
  - UTS2,UTS2B
  - 'DRD1 '
  - 'Kynurenic acid '
  - OXTR:OXT(20-28)
  - AVPR1A,B:AVP(20-28)
  - HTR1B,D,E,F,HTR5A:5HT
  - 'HTR1B '
  - HTR4,6,7
  - 'S1PR5 '
  - 'PTGER3 '
  - 'HTR5A '
  - APLNR:Apelin
  - 'AcCho '
  - CHRM2,CHRM4
  - 'P2RY1 '
  - 'MC4R '
  - P2RY14:UDP-Glc
  - CXCR2 ligands
  - KISS1R
  - 'HCAR1 '
  - XCR1:XCL1,XCL2
  - FFAR4
  - 'CCL3L1(26-93) '
  - 'KISS1R '
  - FPR1:FMLP
  - 'CGA '
  - CXCR6
  - CCR1,2,8:CCL16
  - DA
  - HTR4,6,7:5HT
  - ARBs
  - NLN
  - 'F2RL3(18-385) '
  - HTR1A:5HT
  - 'DDCX '
  - 'CCR2 '
  - 'ATP '
  - NTS(161-163)
  - GPR17:UDP
  - 'CCL7 '
  - receptors
  - 'PENK(100-104) '
  - 'CXCL1(35-107) '
  - CCR6:CCL20
  - 'ADP '
  - 'CXCL2(35-107) '
  - 'UTS2R '
  - G alpha (z)
  - 'OPRK1 '
  - 'FPR1 '
  - 'NMUR1 '
  - GPR183:7alpha,25-dihydroxycholesterol
  - 'GPHA2 '
  - UTP
  - OXT(20-28)
  - receptors:NPY
  - 'CCL13 '
  - 'LHB '
  - 'CMKLR1 '
  - GPR37L1
  - 'LPA '
  - 'CXCL5(37-114) '
  - AVPR2
  - ADORA1,3:Ade-Rib
  - 'NAGLY '
  - LTB4R,LTB4R2:LTB
  - AGT(34-41)
  - 'GPER1 '
  - LPA
  - GPR18
  - GPR143
  - 'PGD2 '
  - CHRM1,3,5
  - H2O
  - TRH
  - MLNR:MLN(24-47)
  - HRH3:Hist
  - 'CCL25 '
  - 'PRLHR '
  - 'CCR3 '
  - 'L-Dopa '
  - 'clopidogrel '
  - Follitropin
  - TRH:TRHR
  - 'APP(672-713) '
  - receptor ligands
  - 'GPHB5 '
  - HTR2A-C
  - CCR8
  - 'SUCCA '
  - SUCNR1
  - 'GPR18 '
  - 'OXT(20-28) '
  - 'SSTR4 '
  - 'EDNRA '
  - 'MTNR1B '
  - Relaxin-3
  - P2RY2
  - 'TRH(114-116) '
  - 'S1PR2 '
  - APLNR
  - 'LTB4R2 '
  - 'MCHR1 '
  - CMKLR1
  - 'UDP '
  - peptides
  - 'PENK(107-111) '
  - ADRB2
  - CCR3,4,5:CCL5(24-91)
  - 'HRH3 '
  - Î²-blockers
  - 'P2RY12 '
  - 'EDNRB '
  - 'PYY(29-64) '
  - FFAR2
  - CX3CR1
  - 'POMC(77-87) '
  - P2RY10:LPA
  - 'CCL20(27-96) '
  - CCR10:CCL27,28
  - NPFF(69-76)
  - CCR2,CCR3
  - OXTR
  - 'CXCL11 '
  - CCL19, CCL21, CCL25
  - DARC:IL8
  - Ade-Rib
  - 'HCRTR2 '
  - 'GALR2 '
  - P2RY11
  - 'GPBAR1: Bile acids'
  - CXCR1 ligands
  - GPR39:Zn2+
  - PTGDR:PGD2
  - FFAR2 ligands
  - ADRA1A,B,D:ADR,NAd
  - PGI2
  - Î²1-agonists:ADBR1
  - GHSR
  - 'EDN1 '
  - 'P2RY13 '
  - '3-hydroxybutyric acid '
  - 'GNRH2(24-33) '
  - 'ALA '
  - DRD2
  - PTGFR:PGF2a
  - CCR7:CCL19,21
  - 'TRH(152-154) '
  - RXFP2 ligands
  - Opioid receptors
  - 'CCR1 '
  - IL8
  - 'mirabegron '
  - TACR1
  - CCL16
  - 'CHRM3 '
  - 'EtCOO- or C2H5COO- '
  - 'LTC4 '
  - MLNR
  - Î±1-antagonists:ADRA1A,B,D
  - 'RXFP1 '
  - '5HT '
  - 'NTSR1 '
  - 'BRS3 '
  - pH sensing receptors
  - PNOC(130-146)
  - OXGR1
  - 'HCAR3 '
  - HCAR2:HCAR2 ligands
  - PTGER3:PGE2
  - '8,11,14-Eicosatrienoic acid '
  - 'FSHB '
  - 'denopamine '
  - 'candesartan '
  - 'PMCH(147-165) '
  - 'HTR2A '
  - DRD3,4:DA
  - TACR3
  - L-Dopa
  - OXER1:5-oxoETE
  - 'OXTR '
  - LPAR6
  - Opioid ligands
  - 'CCR6 '
  - 'CXCR4 '
  - 'LPPR1 '
  - OXER1
  - NPFFR1,NPFFR2
  - GPR35
  - ATP,UTP
  - OPRL1
  - PTGER2,PTGER4
  - 'OPN3 '
  - UTS2R
  - 'TSHR '
  - P2RY6
  - 'SUCNR1 '
  - Hist
  - 'ADRB1 '
  - 'DPA '
  - GNRH ligands
  - 'PROK1 '
  - 'NMU '
  - P2RY4
  - 'NPB(25-53) '
  - ligand
  - 'NPBWR1 '
  - 'HRH1 '
  - EDN3(118-238)
  - 'CNR1 '
  - MCHR1,MCHR2
  - 5-oxoETE
  - peptide
  - 'LACT '
  - CXCR5:CXCL13
  - 2OG
  - PAF
  - CCL13
  - FPR2
  - 'GPR37 '
  - 'ADORA2B '
  - Light-sensing opsins
  - 'POMC(217-234) '
  - '11,14,17-eicosatrienoic acid '
  - 'NPB(25-48) '
  - XCR1
  - NTS(151-163)
  - 'SSTR2 '
  - 'HTR6 '
  - 'CXCL6(38-114) '
  - ESTG
  - 'MC5R '
  - 'NPFF(69-76) '
  - ACKR2
  - S1PR1:S1P
  - 'MC3R(1-360) '
  - NMUR1,NMUR2
  - TAC1(98-107)
  - 'GNRHR '
  - 'CCR4 '
  - Apelin peptides
  - 'CXCR3 '
  - 'RGZ '
  - HRH2
  - P2RY6:UDP
  - Î²3-agonists
  - 'CCL16 '
  - G alpha (i)
  - HRH4:Hist
  - 'CCL19 '
  - 'TAC3 '
  - 'DRD2 '
  - GnRH receptor
  - 'CXCL9 '
  - 'ADORA2A '
  - 'ADRB2 '
  - 'CCL22(25-93) '
  - 'PSAP(?-?) '
  - 'NPBWR2 '
  - receptor:opioid
  - 'CCL17 '
  - 18(R)-RvE1
  - TSHR
  - '7alpha,25-dihydroxycholesterol '
  - receptors:H+
  - leukotrienes
  - CCKAR,CCKBR
  - 'GPR39 '
  - 'DARC '
  - PTGDR2
  - P2RY2:ATP
  - 'PSAP(326-340) '
  - CYSLTR1:LTC4,LTD4,LTE4
  - 'O-octanoyl-L-serine-GHRL-1(24-50) '
  - 'LPAR3 '
  - PMCH(147-165)
  - 'ADRA2C '
  - 'KEL '
  - NMUR1,NMUR2:NMU
  - HCAR3 ligands
  - CXCR3:CXCR3 ligands
  - 'OPN5 '
  - P2RY1
  - 'OXGR1 '
  - 'FFAR4 '
  - 'HRH4 '
  - 'LTB4 '
  - 'ADRA1A '
  - 'TAAR2 '
  - 'GPR35 '
  - 'thrombin light chain '
  - P2RY13:ADP
  - CYSLTR1:CYSLTR1
  - 'FFAR2 '
  - 'DRD5 '
  - XCL1,XCL2
  - ADORA2A,B:Ade-Rib
  - 'QRFP '
  - 'NMB(47-56) '
  - NMUR2:NMS
  - CCR7
  - 'SSTR3 '
  - 'PF4(48-101) '
  - S1P
  - GPR18:NAGLY
  - Kynurenic acid
  - 'HTR2B '
  - Relaxin-2, Relaxin-3
  - 'Bradykinin '
  - '18(S)-RvE1 '
  - LACT
  - 'PGF2a '
  - 'GALR3 '
  - FFAR1
  - Bile acids
  - 'OPN1SW '
  - CCL19,21
  - 'CXCR1 '
  - 'ELDA '
  - GPR183
  - GnRH receptor:GNRH
  - 'TAAR1 '
  - ligands
  - fragments
  - HTR2A-C:5HT
  - NTSR1,NTSR2
  - HRH2:histamine
  - 'GPR183 '
  - ADRB1
  - G alpha (q)
  - 'NMUR2 '
  - 'LPPR4 '
  - NPSR1
  - PTGDR2:PGD2
  - 'Valerate '
  - 'CHRM4 '
  - 'GPR31 '
  - 'CCL2 '
  - S1PR1:S1PR1 agonists
  - 'PENK(136-140) '
  - DRD3,4
  - CYSLTR2:LTC4,LTD4,LTE4
  - 'CCL11 '
  - 'CCR9 '
  - GPER1:ESTG
  - PSAP fragments
  - 'CXCL10(22-98) '
  - 'FFAR3 '
  - '5-oxoETE '
  - Neuropeptides B/W
  - CCR8:CCL1
  - TACR2
  - CX3CR1:CX3CL1
  - 'CCL3(24-92) '
  - PRLH peptides
  - 'ADRA1D '
  - 'TXA2 '
  - 'RXFP2 '
  - 'POMC(138-150) '
  - 'POMC(237-241) '
  - P2RY10
  - DARC
  - 12(S)-HETE
  - Cannabinoids
  - 'HCOOH '
  - 'RLN3(26-52) '
  - 'TAC1(58-68) '
  - '2AG '
  - Î±1-agonists:ADRA1A,B,D
  - 'TAAR5 '
  - 'AGTR2 '
  - MLT
  - 'CXCL16 '
  - Neuropeptide Y
  - 'TAAR8 '
  - 'PTAFR '
  - 'PROK2 '
  - FPR2 ligands
  - GPR37
  - RXFP1:Relaxin-2,Relaxin-3
  - 'CCL28 '
  - CYSLTR2
  - Opioid
  - LHCGR
  - receptor:bombesin-like peptide
  - ECE2
  - GPR17
  - 'ADRA2A '
  - 'LHCGR '
  - PRLHR:PRLH peptides
  - 'PALM '
  - CCRL1
  - 'HTR1E '
  - 'GAL '
  - 'ADORA3 '
  - FPR3:FPR3 ligands
  - ADRA2A,B,C
  - 'BUT '
  - S1PR2-5:S1P
  - P2RY12:P2RY12
  - glyco-Lutropin
  - 'BDKRB2 '
  - 'TACR2 '
  - 'NAd '
  - ADRA2A,B,C:ADR,NAd
  - PROK1,PROK2
  - 'MLNR '
  - 'NPS '
  - 'AVPR1A '
  - LPAR1,2,3,5:LPA
  - 'LPAR5 '
  - AVPR2:AVP(20-28)
  - P2RY12 antagonists
  - LTB4
  - Resolvin E1:CMKLR1
  - 'PTGFR '
  - CX3CL1
  - 'C3AR1 '
  - CXCR1:CXCR1 ligands
  - 'H+ '
  - 'Zn2+ '
  - 'Somatostatin '
  - 'ADORA1 '
  - GPER1
  - 'P2RY14 '
  - 'MTNR1A '
  - 'MYSA '
  - SUCNR1:SUCCA
  - NMUR2
  - CXCR4,7
  - EDN1
  - 'GNRHR2 '
  - GPR31:12(S)-HETE
  - PTGIR:PGI2
  - 'QRFPR '
  - 'CYSLTR1 '
  - ADRA1A,B,D
  - 'POMC(237-267) '
  - receptors:melatonin
  - 'GALR1 '
  - ACKR2:CCBP2 ligands
  - MSH:Melanocortin
  - Thrombin:Proteinase-activated receptors
  - 'PTGIR '
  - FFAR3
  - 'HEBP1(1-21) '
  - 'UTS2 '
  - receptor:Nociceptin
  - FFAR4 ligands
  - 'MLT '
  - 'CXCR2 '
  - 'C5a-desArg '
  - 'MT-RNR2 '
  - 'AVP(20-28) '
  - 'XCR1 '
  - Sphingolipid
  - GAL
  - AcCho
  - 'F2R(27-425) '
  - CCL27,28
  - FFAR1:FFAR1 ligands
  - PRLHR
  - 'MCHR2 '
  - 'EDN3(97-117) '
  - 'AGTR1 '
  - PEA
  - NPSR1:NPS
  - GPR35:Kynurenic acid
  - 'GPR143 '
  - CCK
  - H+
  - 'LTE4 '
  - 'CCA '
  - 'IL8 '
  - 'GPR68 '
  - 'P2RY6 '
  - 'FMLP '
  - Bombesin-like
  - LPAR4
  - CCR10
  - CXCL16
  - 'FFAR1 '
  - 'HTR7 '
  - Melanocortin
  - CCL19
  - 'NTSR2 '
  - 'BDKRB1 '
  - UTSR:UTS2,UTS2B
  - 'TACR1 '
  - 'GPR17 '
  - Trace
  - 'LPPR3 '
  - 'P2RY2 '
  - HCAR1:LACT
  - 'NPY '
  - 'Photon '
  - 'PGE2 '
  - 'INSL5(115-135) '
  - 'TRH(135-137) '
  - C3a
  - 'STEA '
  - EDNRA,EDNRB
  - 'HCRTR1 '
  - PTGIR
  - GPR17:Cysteinyl
  - CXCR6:CXCL16
  - RXFP2
  - 'CH3COO- '
  - 'INSL3(21-55) '
  - MC2R
  - FPR3 ligands
  - 'RLN2(162-185) '
  - receptor:Bradykinin
  - CCR3,4,5
  - Pi
  - (factor IIa)
  - ADRB1:ADR,NAd
  - 'PAF '
  - ADRB3
  - 'CCKBR '
  - FFAR1 ligands
  - 'TRH(84-86) '
  - FFAR3 ligands
  - 'LTD4 '
  - 'NPY2R '
  - ECE1
  - 'O-octanoyl-L-serine-GHRL-1(24-51) '
  - NAGLY
  - CXCR2:CXCR2 ligands
  - HCRT(70-97)
  - C5a
  - GPR31
  - 'montelukast '
  - 'CCL1 '
  - 'PTGER4 '
  - DRD1,5
  - AVP(20-28)
  - 'DCA '
  - CNRs:Cannabinoids
  - KISS1R:KISS1(68-121)
  - 'CDCA '
  - CHRM2,CHRM4:AcCho
  - 'PRLH(23-53) '
  - 'Dynorphins '
  - 'Ade-Rib '
  - Acyl Ghrelin
  - 'HTR1D '
  - '2OG '
  - CNRs
  - receptor:PEA
  - 'EDN2 '
  - 'GRPR '
  - CXCR4,7:CXCL12
  - pH sensing
  - P2RY14
  - GALR1-3:GAL
  - signalling events
  - GPR39
  - 'LCHA '
  - 'C5AR2 '
  - CCR1,2,8
  - Melatonin
  - PROKR1,PROKR2
  - 'APLN(50-77) '
  - TBXA2R
  - CXCR5
  - TACR1:TAC1(58-68)
  - HCAR3
  - 'CCR5 '
  - C5AR2 ligands
  - 'APLN(42-77) '
  - 'FPR3 '
  - Photon
  - RXFP1
  - 'APLN(47-77) '
  - 'PTGDR '
  - 'APLNR '
  - 'PROKR1 '
  - PTGER1:PGE2
  - 'ESTG '
  - Thyrotropin,
  - 'C3a '
  - AVPR1A,B
  - PTGER2,PTGER4:PGE2
  - 'RXFP4 '
  - 'CCR8 '
  - 'TRHR '
  - UDP-Glc
  - PTAFR
  - FSHR
  - ADRB1,2,3
  - 'A61603 '
  - 'S1PR3 '
  - FSHR:Follitropin
  - LH receptor:LH
  - TSHR:Thyrotropin
  - 'HCRT(34-66) '
  - Endothelin
  - 'CHRM5 '
  - OPN4
  - 'P2RY11 '
  - 'OPN4 '
  - TAC3
  - Somatostatin
  - 'PENK(230-234) '
  - 1,2-DAG
  - CCL20(27-96)
  - 18(S)-RvE1,
  - 'GHSR '
  - PGE2
  - 'DecS-GHRL-1(24-51) '
  - 'ACKR2 '
  - EDN1(53-90)
  - 'F2RL1(37-397) '
  - 'GRP(24-50) '
  - Zn2+
  - 'OPRM1 '
  - HCRTR1
  - 'C5AR1 '
  - 'GPR37L1 '
  - Bradykinin
  - P2RY4:UTP
  - 'C3a-desArg '
  - antagonists
  - PTGER1
  - CYSLTR1
  - FPR1
  - 'NPY5R '
  - 'CXCR7 '
  - QRFP
  - 'HTR4 '
  - PROKR1,PROKR2:PROK1,PROK2
  - CCKAR,CCKBR:CCK
  - 'POMC(138-176) '
  - 'LXA4 '
  - 'INSL3(106-131) '
  - CCRL2
  - CCR9
  - XK:KEL:Zn2+
  - 'S1P '
  - NPY receptor ligands
  - 'CCKAR '
  - 'HRH2 '
  - G alpha (12/13)
  - HRH4
  - LPPR4(LPPR1-3,5)
  - 'DA '
  license: CC0
  name: Class A/1 (rhodopsin-like receptors)
seo: CreativeWork
title: Class A/1 (rhodopsin-like receptors)
wpid: WP4419
---